Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia von Furman, Richard R, Sharman, Jeff P, Coutre, Steven E, Cheson, Bruce D, Pagel, John M, Hillmen, Peter, Barrientos, Jacqueline C, Zelenetz, Andrew D, Kipps, Thomas J, Flinn, Ian, Ghia, Paolo, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole, Coiffier, Bertrand, Pettitt, Andrew R, Ma, Shuo, Stilgenbauer, Stephan, Cramer, Paula, Aiello, Maria, Johnson, Dave M, Miller, Langdon L, Li, Daniel, Jahn, Thomas M, Dansey, Roger D, Hallek, Michael, O'Brien, Susan M

Volltext

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma von Gopal, Ajay K, Kahl, Brad S, de Vos, Sven, Wagner-Johnston, Nina D, Schuster, Stephen J, Jurczak, Wojciech J, Flinn, Ian W, Flowers, Christopher R, Martin, Peter, Viardot, Andreas, Blum, Kristie A, Goy, Andre H, Davies, Andrew J, Zinzani, Pier Luigi, Dreyling, Martin, Johnson, Dave, Miller, Langdon L, Holes, Leanne, Li, Daniel, Dansey, Roger D, Godfrey, Wayne R, Salles, Gilles A

Volltext

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia von O'Brien, Susan M., Lamanna, Nicole, Kipps, Thomas J., Flinn, Ian, Zelenetz, Andrew D., Burger, Jan A., Keating, Michael, Mitra, Siddhartha, Holes, Leanne, Yu, Albert S., Johnson, David M., Miller, Langdon L., Kim, Yeonhee, Dansey, Roger D., Dubowy, Ronald L., Coutre, Steven E.

Volltext

Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab von Lacey, David L., Boyle, William J., Simonet, W. Scott, Kostenuik, Paul J., Dougall, William C., Sullivan, John K., Martin, Javier San, Dansey, Roger

Volltext

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study von Fizazi, Karim, Prof, Carducci, Michael, MD, Smith, Matthew, MD, Damião, Ronaldo, Prof, Brown, Janet, MD, Karsh, Lawrence, MD, Milecki, Piotr, MD, Shore, Neal, MD, Rader, Michael, MD, Wang, Huei, PhD, Jiang, Qi, PhD, Tadros, Sylvia, MPH, Dansey, Roger, MD, Goessl, Carsten, MD

Volltext

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Mu... von HENRY, David H, COSTA, Luis, VON MOOS, Roger, WILLENBACHER, Wolfgang, WOLL, Penella J, JIANMING WANG, QI JIANG, SUSIE JUN, DANSEY, Roger, YEH, Howard, GOLDWASSER, Francois, HIRSH, Vera, HUNGRIA, Vania, PRAUSOVA, Jana, SCAGLIOTTI, Giorgio Vittorio, SLEEBOOM, Harm, SPENCER, Andrew, VADHAN-RAJ, Saroj

Volltext

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time... von SMITH, Matthew R, SAAD, Fred, VAN VELDHUIZEN, Peter, MOROTE, Juan, ZHISHEN YE, DANSEY, Roger, GOESSL, Carsten, OUDARD, Stephane, SHORE, Neal, FIZAZI, Karim, SIEBER, Paul, TOMBAL, Bertrand, DAMIAO, Ronaldo, MARX, Gavin, MILLER, Kurt

Volltext

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study von Stopeck, Alison T, Lipton, Allan, Body, Jean-Jacques, Steger, Guenther G, Tonkin, Katia, de Boer, Richard H, Lichinitser, Mikhail, Fujiwara, Yasuhiro, Yardley, Denise A, Viniegra, María, Fan, Michelle, Jiang, Qi, Dansey, Roger, Jun, Susie, Braun, Ada

Volltext

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial von Smith, Matthew R, Prof, Saad, Fred, Prof, Coleman, Robert, Prof, Shore, Neal, MD, Fizazi, Karim, Prof, Tombal, Bertrand, Prof, Miller, Kurt, Prof, Sieber, Paul, MD, Karsh, Lawrence, MD, Damião, Ronaldo, Prof, Tammela, Teuvo L, Prof, Egerdie, Blair, MD, Van Poppel, Hendrik, Prof, Chin, Joseph, Prof, Morote, Juan, Prof, Gómez-Veiga, Francisco, MD, Borkowski, Tomasz, Prof, Ye, Zhishen, PhD, Kupic, Amy, MA, Dansey, Roger, MD, Goessl, Carsten, MD

Volltext

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study von Thomas, David, Dr, Henshaw, Robert, MD, Skubitz, Keith, Prof, Chawla, Sant, MD, Staddon, Arthur, Prof, Blay, Jean-Yves, Prof, Roudier, Martine, MD, Smith, Judy, BA, Ye, Zhishen, PhD, Sohn, Winnie, PhD, Dansey, Roger, MD, Jun, Susie, MD

Volltext

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia von FURMAN, Richard R, SHARMAN, Jeff P, GHIA, Paolo, ERADAT, Herbert, ERVIN, Thomas, LAMANNA, Nicole, COIFFIER, Bertrand, PETTITT, Andrew R, SHUO MA, STILGENBAUER, Stephan, CRAMER, Paula, AIELLO, Maria, COUTRE, Steven E, JOHNSON, Dave M, MILLER, Langdon L, LI, Daniel, JAHN, Thomas M, DANSEY, Roger D, HALLEK, Michael, O'BRIEN, Susan M, CHESON, Bruce D, PAGEL, John M, HILLMEN, Peter, BARRIENTOS, Jacqueline C, ZELENETZ, Andrew D, KIPPS, Thomas J, FLINN, Ian

Volltext

Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid von MARTIN, Miguel, BELL, Richard, RITCHIE, Diana, STEGER, Gunther G, STOPECK, Alison, VOGEL, Charles, FAN, Michelle, QI JIANG, CHUNG, Karen, DANSEY, Roger, BRAUN, Ada, BOURGEOIS, Hugues, BRUFSKY, Adam, DIEL, Ingo, ENIU, Alexandru, FALLOWFIELD, Lesley, FUJIWARA, Yasuhiro, JASSEM, Jacek, PATERSON, Alexander H. G

Volltext

Abstract IA18: Clinical validation of PI3Kδ as a therapeutic target in B-cell malignancy von Dansey, Roger

Volltext

High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes von McSweeney, Peter A., Nash, Richard A., Sullivan, Keith M., Storek, Jan, Crofford, Leslie J., Dansey, Roger, Mayes, Maureen D., McDonagh, Kevin T., Nelson, J. Lee, Gooley, Theodore A., Holmberg, Leona A., Chen, C.S., Wener, Mark H., Ryan, Katherine, Sunderhaus, Julie, Russell, Ken, Rambharose, John, Storb, Rainer, Furst, Daniel E.

Volltext

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results fr... von Sierra, Jorge, Szer, Jeffrey, Kassis, Jeannine, Herrmann, Richard, Lazzarino, Mario, Thomas, Xavier, Noga, Stephen J, Baker, Nigel, Dansey, Roger, Bosi, Alberto

Volltext

New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016 von Adusumilli, Prasad S, Cha, Edward, Cornfeld, Mark, Davis, Thomas, Diab, Adi, Dubensky, Thomas W, Evans, Elizabeth, Grogan, Jane L, Irving, Bryan A, Leidner, Rom S, Olwill, Shane A, Soon-Shiong, Patrick, Triebel, Frederic, Tuck, David, Bot, Adrian, Dansey, Roger D, Drake, Charles G, Freeman, Gordon J, Ibrahim, Ramy, Patel, Salil, Chen, Daniel S

Volltext

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tu... von Henry, David, Vadhan-Raj, Saroj, Hirsh, Vera, von Moos, Roger, Hungria, Vania, Costa, Luis, Woll, Penella J, Scagliotti, Giorgio, Smith, Geoffrey, Feng, Amy, Jun, Susie, Dansey, Roger, Yeh, Howard

Volltext

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid von CLEELAND, Charles S, BODY, Jean-Jacques, LIPTON, Allan, DE BOER, Richard, SALVAGNI, Stefania, TOSELLO OLIVEIRA, Celia, YI QIAN, QI JIANG, DANSEY, Roger, BRAUN, Ada, CHUNG, Karen, STOPECK, Alison, VON MOOS, Roger, FALLOWFIELD, Lesley, MATHIAS, Susan D, PATRICK, Donald L, CLEMONS, Mark, TONKIN, Katia, MASUDA, Norikazu

Volltext

High‐Dose Chemotherapy and Peripheral Blood Progenitor Cell Transplantation in the Treatment of Breast Cancer von Peters, William P., Dansey, Roger D., Klein, Jared L., Baynes, Roy D.

Volltext

Anti-Thrombin III in the Management of Hematopoietic Stem-Cell Transplantation-Associated Toxicity von Ibrahim, Rami B, Peres, Edward, Dansey, Roger, Abidi, Muneer H, Abella, Esteban M, Klein, Jared

Volltext